Claret Asset Management Corp Invests $9.30 Million in Indivior PLC (NASDAQ:INDV)

Claret Asset Management Corp acquired a new stake in shares of Indivior PLC (NASDAQ:INDV) in the fourth quarter, HoldingsChannel.com reports. The firm acquired 748,486 shares of the company’s stock, valued at approximately $9,304,000. Indivior comprises about 1.5% of Claret Asset Management Corp’s investment portfolio, making the stock its 18th biggest holding.

A number of other institutional investors also recently bought and sold shares of the company. Marshall Wace LLP raised its position in Indivior by 659.7% in the fourth quarter. Marshall Wace LLP now owns 506,782 shares of the company’s stock worth $6,299,000 after acquiring an additional 440,072 shares during the period. CenterBook Partners LP grew its holdings in Indivior by 105.5% during the fourth quarter. CenterBook Partners LP now owns 1,147,841 shares of the company’s stock valued at $14,268,000 after purchasing an additional 589,158 shares during the period. Rathbones Group PLC increased its position in Indivior by 11.6% in the fourth quarter. Rathbones Group PLC now owns 14,284 shares of the company’s stock worth $183,000 after buying an additional 1,483 shares in the last quarter. Legal & General Group Plc lifted its position in shares of Indivior by 1.4% during the 4th quarter. Legal & General Group Plc now owns 715,920 shares of the company’s stock valued at $9,181,000 after buying an additional 9,978 shares in the last quarter. Finally, Landscape Capital Management L.L.C. purchased a new stake in Indivior in the 4th quarter worth approximately $978,000. Institutional investors own 60.33% of the company’s stock.

Analysts Set New Price Targets

Several brokerages recently weighed in on INDV. Piper Sandler dropped their target price on shares of Indivior from $16.00 to $13.00 and set an “overweight” rating for the company in a report on Thursday, March 6th. Rodman & Renshaw assumed coverage on Indivior in a research report on Tuesday, January 28th. They issued a “buy” rating and a $16.00 price objective on the stock. Finally, RODMAN&RENSHAW upgraded Indivior to a “strong-buy” rating in a research report on Tuesday, January 28th.

Indivior Trading Down 0.6 %

Shares of Indivior stock opened at $9.01 on Friday. Indivior PLC has a 12 month low of $7.33 and a 12 month high of $19.13. The stock’s fifty day moving average price is $9.50 and its 200-day moving average price is $10.32. The firm has a market cap of $1.24 billion, a P/E ratio of -25.74 and a beta of 0.93.

Indivior (NASDAQ:INDV) last issued its quarterly earnings data on Thursday, February 20th. The company reported $0.32 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.32. Indivior had a negative net margin of 3.96% and a negative return on equity of 241.73%. The company had revenue of $298.00 million for the quarter, compared to analyst estimates of $262.35 million. Analysts forecast that Indivior PLC will post 1.22 earnings per share for the current year.

About Indivior

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.